MacroGenics
MGNX
#9386
Rank
A$0.13 B
Marketcap
A$2.09
Share price
4.51%
Change (1 day)
-61.50%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.13 Billion

As of December 2025 MacroGenics has a market cap of A$0.13 Billion. This makes MacroGenics the world's 9386th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.13 B-59.37%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of MacroGenics was reported to be:

A$0.12 Billion
by Nasdaq info icon info icon
A$0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
A$1.80 B 1,265.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.87 B 163,689.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$364.44 B 275,132.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$223.02 B 168,333.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$254.50 B 192,102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.325 T 1,001,292.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$155.27 B 117,165.60%๐Ÿ‡บ๐Ÿ‡ธ USA